X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs TEVA PHARMA (Israel) - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   TEVA PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
TEVA PHARMA
Dec-13
PIRAMAL ENTERPRISES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,3032,873-   
Low Rs1,7972,495-   
Sales per share (Unadj.) Rs716.51,648.6-  
Earnings per share (Unadj.) Rs79.7103.0-  
Cash flow per share (Unadj.) Rs107.9236.2-  
Dividends per share (Unadj.) Rs28.0090.15-  
Dividend yield (eoy) %1.13.4 32.7%  
Book value per share (Unadj.) Rs1,477.51,831.3-  
Shares outstanding (eoy) m184.45848.00-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.61.6 218.6%   
Avg P/E ratio x32.026.1 122.7%  
P/CF ratio (eoy) x23.611.4 208.0%  
Price / Book Value ratio x1.71.5 117.7%  
Dividend payout %35.187.5 40.1%   
Avg Mkt Cap Rs m470,2922,276,015 20.7%   
No. of employees `0007.844.9 17.4%   
Total wages/salary Rs m22,5040-   
Avg. sales/employee Rs Th16,899.431,104.9 54.3%   
Avg. wages/employee Rs Th2,877.70-   
Avg. net profit/employee Rs Th1,879.91,943.1 96.8%   
INCOME DATA
Net Sales Rs m132,1531,398,009 9.5%  
Other income Rs m3,1280-   
Total revenues Rs m135,2811,398,009 9.7%   
Gross profit Rs m66,290382,846 17.3%  
Depreciation Rs m5,202113,002 4.6%   
Interest Rs m44,09727,459 160.6%   
Profit before tax Rs m20,119242,384 8.3%   
Minority Interest Rs m3,1941,101 290.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-159,112 0.0%   
Tax Rs m8,611-2,959 -291.0%   
Profit after tax Rs m14,70187,333 16.8%  
Gross profit margin %50.227.4 183.2%  
Effective tax rate %42.8-1.2 -3,505.8%   
Net profit margin %11.16.2 178.1%  
BALANCE SHEET DATA
Current assets Rs m122,742944,210 13.0%   
Current liabilities Rs m310,810823,431 37.7%   
Net working cap to sales %-142.38.6 -1,647.2%  
Current ratio x0.41.1 34.4%  
Inventory Days Days2391 25.4%  
Debtors Days Days3996 40.5%  
Net fixed assets Rs m116,904456,621 25.6%   
Share capital Rs m3693,441 10.7%   
"Free" reserves Rs m272,1610-   
Net worth Rs m272,5301,552,923 17.5%   
Long term debt Rs m270,196714,833 37.8%   
Total assets Rs m856,2613,194,900 26.8%  
Interest coverage x1.59.8 14.8%   
Debt to equity ratio x1.00.5 215.4%  
Sales to assets ratio x0.20.4 35.3%   
Return on assets %6.93.6 191.1%  
Return on equity %5.45.6 95.9%  
Return on capital %12.44.9 251.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,3120-   
CASH FLOW
From Operations Rs m-115,975222,770 -52.1%  
From Investments Rs m-8,265-78,937 10.5%  
From Financial Activity Rs m107,525-267,228 -40.2%  
Net Cashflow Rs m-16,650-123,394 13.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.82 Rs / USD

Compare PIRAMAL ENTERPRISES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare PIRAMAL ENTERPRISES With: SANOFI INDIA  DISHMAN PHARMA  ALEMBIC LTD  FULFORD INDIA  NATCO PHARMA  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views On News

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks (Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock (The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Jul 19, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS